` LXG (Lexagene Holdings Inc) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

LXG
vs
S&P TSX Composite Index (Canada)

Over the past 12 months, LXG has underperformed S&P TSX Composite Index (Canada), delivering a return of 0% compared to the S&P TSX Composite Index (Canada)'s 22% growth.

Stocks Performance
LXG vs S&P TSX Composite Index (Canada)

Loading
LXG
S&P TSX Composite Index (Canada)
Add Stock
www.alphaspread.com

Performance Gap
LXG vs S&P TSX Composite Index (Canada)

Loading
LXG
S&P TSX Composite Index (Canada)
Difference
www.alphaspread.com

Performance By Year
LXG vs S&P TSX Composite Index (Canada)

Loading
LXG
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
Lexagene Holdings Inc vs Peers

S&P TSX Composite Index (Canada)
LXG
ABT
ISRG
BSX
SYK
Add Stock

Lexagene Holdings Inc
Glance View

Market Cap
14.8m CAD
Industry
Health Care

Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 34 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The firm's MiQLab is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its on-site, automated rapid pathogen detection technology is used for testing in human clinical diagnostics, veterinary diagnostics, food safety, and more. Its veterinary diagnostics system enables veterinarians to rapidly identify infectious pathogens and antibiotic resistance factors in cats and dogs, providing actionable insights in initial diagnosis and prescribed therapies.

LXG Intrinsic Value
Not Available
Back to Top